65,437 trials
Advanced Solid Tumors · Recurrent Solid Tumors
Primary: PK Outcome: Cmax of ONO-4538 — 26.0; 64.3; 242.0 µg/mL
Barth Syndrome
Primary: Part 1: Distance Walked During the 6-Minute Walk Test (6MWT) by Visit — 400.1; 412.6; 443.1; 443.9 meters
TTR Cardiac Amyloidosis
Primary: Sudden Death — 0 Participants
Total Hip Replacement · Analgesia
Primary: Post-operative Pain Score in Numeric Rating Scale (NRS) From 0 (no Pain) to 10 (Extreme Pain) — 3; 3 score on a scale
Smoking Cessation
Primary: Number of Treatment-Emergent Adverse Events [Safety and Tolerability] — 0; 1; 1; 1 Participants
Contact Lens Wearer
Primary: Normalized logMAR Visual Acuity — -0.01; -0.02 LogMAR
Persistent Atrial Fibrillation · Ventricular Tachycardia
Primary: Rate of Subjects With Acute Success — 287; 14 Participants
Healthy Volunteer
Primary: Fasting Gastric Volume as Measured by Single Photon Emission Computed Tomography (SPECT) — 178.8; 191.1 mL
Refractive Ametropia
Primary: Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR) — -0.08; -0.06 logMAR
Smoking Cessation
Primary: Feasibility of Intervention Measure — 4 units on a scale
Myopia
Primary: Subjective Overall Score — 80.2; 88.2 score on a scale
Bipolar I Disorder
Primary: Change From Baseline to Week 4 in Young Mania Rating Scale (YMRS) Total Score — -14.0; -10.0 Change from Baseline in YMRS Total Score
Pelvic Organ Prolapse · Stress Urinary Incontinence · Overactive Bladder
Primary: Patient Knowledge — 60; 72 percentage of questions answered correct — p=0.06
Urinary Incontinence
Primary: Change in Health-related Quality of Life From Baseline (Visit 1) to Termination (Visit 5), Measured by the Intermittent Self-Catheterization Questionnaire Index Score…
Opioid-use Disorder
Primary: Number of Participants With Successful Rapid Induction — 14 Participants